Cargando…
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options. We report our 12-y experience of antithymocyte globulin (ATG) as second-line CLAD therapy. METHODS. Clinical and lung function data were collect...
Autores principales: | Kotecha, Sakhee, Paul, Eldho, Ivulich, Steve, Fuller, Jeremy, Paraskeva, Miranda, Levvey, Bronwyn, Snell, Gregory, Westall, Glen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969305/ https://www.ncbi.nlm.nih.gov/pubmed/33748410 http://dx.doi.org/10.1097/TXD.0000000000001134 |
Ejemplares similares
-
Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022) -
An update on chronic lung allograft dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2020) -
Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
por: Li, Jenny, et al.
Publicado: (2023) -
Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017) -
Review: immunosuppression for the lung transplant patient
por: Kotecha, Sakhee, et al.
Publicado: (2021)